04:33 PM EDT, 04/09/2024 (MT Newswires) -- Pascal Deschatelets, Chief Scientific Officer, on April 08, 2024, sold 69,107 shares in Apellis Pharmaceuticals ( APLS ) for $3,743,605. Following the Form 4 filing with the SEC, Deschatelets has control over a total of 1,115,983 shares of the company, with 1,115,983 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760224012710/xslF345X03/form4.xml